HbA1c, diabetes and cognitive decline: the English Longitudinal Study of Ageing
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The aim of the study was to evaluate longitudinal associations between HbA 1c levels, diabetes status and subsequent cognitive decline over a 10 year follow-up period. Data from wave 2 (2004–2005) to wave 7 (2014–2015) of the English Longitudinal Study of Ageing (ELSA) were analysed. Cognitive function was assessed at baseline (wave 2) and reassessed every 2 years at waves 3–7. Linear mixed models were used to evaluate longitudinal associations. The study comprised 5189 participants (55.1% women, mean age 65.6 ± 9.4 years) with baseline HbA 1c levels ranging from 15.9 to 126.3 mmol/mol (3.6–13.7%). The mean follow-up duration was 8.1 ± 2.8 years and the mean number of cognitive assessments was 4.9 ± 1.5. A 1 mmol/mol increment in HbA 1c was significantly associated with an increased rate of decline in global cognitive z scores (−0.0009 SD/year, 95% CI −0.0014, −0.0003), memory z scores (−0.0005 SD/year, 95% CI −0.0009, −0.0001) and executive function z scores (−0.0008 SD/year, 95% CI −0.0013, −0.0004) after adjustment for baseline age, sex, total cholesterol, HDL-cholesterol, triacylglycerol, high-sensitivity C-reactive protein, BMI, education, marital status, depressive symptoms, current smoking, alcohol consumption, hypertension, CHD, stroke, chronic lung disease and cancer. Compared with participants with normoglycaemia, the multivariable-adjusted rate of global cognitive decline associated with prediabetes and diabetes was increased by −0.012 SD/year (95% CI −0.022, −0.002) and −0.031 SD/year (95% CI −0.046, −0.015), respectively ( p for trend <0.001). Similarly, memory, executive function and orientation z scores showed an increased rate of cognitive decline with diabetes. Significant longitudinal associations between HbA 1c levels, diabetes status and long-term cognitive decline were observed in this study. Future studies are required to determine the effects of maintaining optimal glucose control on the rate of cognitive decline in people with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These tests have been shown to have high validity and reliability in the studies of others [16–18].”
From Digital exclusion and cognitive impairment in older people: findings from five longitudinal studies (2024) · cites this paper as [16]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s062 · Cited by 5,491
Prediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958 · cited 1×
“4%] [14]) and/or diabetes are associated with accelerated cognitive decline in an elderly population with normal cognition at baseline; and (2) to examine whether people with diabetes with better glycaemic control, as measured by HbA1c levels, show a similar or decreased rate of subsequent cognitive decline.”
BackgroundThe projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,666
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444
Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187
Cohort profile: The English longitudinal study of ageing
Steptoe, A., Breeze, E., Banks, J., & Nazroo, J. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dys168 · Cited by 1,779
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults
Selvin, E., Steffes, M. W., Zhu, H., Matsushita, K., Wagenknecht, L., Pankow, J., Coresh, J., & Brancati, F. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908359 · Cited by 1,544
Research works printed but not linked: 1
- Graig R Deverill C Pickering K Spronston K Mindell J Quality control of blood saliva and urine analytes Health Survey for England 2004: methodology and documentation 2006 London The Information Centre
Cited by
Items 101–200 of 279
Guan, T., Zhang, C., Zou, X., Chen, C., Zhou, L., Wu, X., & Hao, J. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191912574 · Cited by 15
“Furthermore, the reliability and validity of the above tests has been well-proven [32,33].”
BackgroundYuan, Y., Zhang, Y., Lei, M., Guo, X., Yang, X., Ouyang, C., Liu, C., & Chen, Q. (2024) · International Journal of Endocrinology · doi:10.1155/2024/9294113 · Cited by 18
Wu, Y., Kong, X., Feng, W., Xing, F., Zhu, S., Lv, B., Liu, B., Li, S., Sun, Y., & Wu, Y. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.08.175 · Cited by 20
Zheng, F., Xie, W., Li, C., Gao, D., & Liang, J. (2023) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glac251 · Cited by 12
Self-citationRuiz, M. A., Hu, Y., Martikainen, P., & Bobák, M. (2023) · Innovation in Aging · doi:10.1093/geroni/igad064 · Cited by 16
“This is a widely implemented approach in longitudinal analyses of cognition z -scores (Ma et al., 2020; Zheng et al., 2018).”
Yu, Q., Jiang, X., Yan, J., & Yu, H. (2024) · Geriatric Nursing · doi:10.1016/j.gerinurse.2024.05.018 · Cited by 15
Associations Between Atherosclerosis and Subsequent Cognitive Decline: A Prospective Cohort Study
Liang, J., Pan, Y., Zhang, W., Gao, D., Ma, J., Zhang, Y., Ji, M., Dai, Y., Liu, Y., Wang, Y., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.036696 · Cited by 17
Self-citationLopez‐Cepero, A. A., McClain, A. C., Rosal, M. C., Tucker, K. L., & Mattei, J. (2021) · Psychosomatic Medicine · doi:10.1097/psy.0000000000001013 · Cited by 17
Schaich, C. L., Bancks, M. P., Hayden, K. M., Ding, J., Rapp, S. R., Bertoni, A. G., Heckbert, S. R., Hughes, T. M., & Mongraw‐Chaffin, M. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad444 · Cited by 14
Abdullah, Z., Cui, Y., Platt, R. W., Renoux, C., Azoulay, L., Xia, C., & Yu, O. H. Y. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2024-004541 · Cited by 13
Cao, B., Zhou, R., Chen, H.-W., Liang, Y., Liu, K., Fan, W.-D., Huang, R.-D., Huang, Y., Zhong, Q., & Wu, X. (2024) · The Gerontologist · doi:10.1093/geront/gnae139 · Cited by 15
Ma, Y., Li, C., Hua, R., Yang, C., Xie, W., & Zhang, L. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221162 · Cited by 11
“The cognitive Z scores have been widely used [15–21].”
Self-citationYuan, Z., Liu, H., Zhou, R., Gu, S., Wu, K., Huang, Z., Zhong, Q., Huang, Y., Chen, H., & Wu, X. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-03998-9 · Cited by 14
Huang, Q., Chen, H., Zhang, P., Yang, J., Liu, D., Li, Z., & Mao, C. (2025) · Age and Ageing · doi:10.1093/ageing/afaf186 · Cited by 10
“Thus, the true effect size may be larger than observed in this study, but the study found good validity and consistency across all tests in assessing cognitive function [51, 52].”
Zhu, Y., Li, C., Gao, D., Huang, X., Zhang, Y., Ji, M., Zheng, F., & Xie, W. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.91 · Cited by 12
Self-citationYingxu, L., Tan, X., & Fangyi, L. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.04.039 · Cited by 12
Alzheimer's Disease and Oral-Systemic Health: Bidirectional Care Integration Improving Outcomes
Rice, A. O. (2021) · Frontiers in Oral Health · doi:10.3389/froh.2021.674329 · Cited by 14
Cheng, F., Ju, Y., Chen, X., & Jia, H. (2023) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5877 · Cited by 12
Zhou, X., Qin, J., Li, H., Chen, J., Zhang, Q., & Ye, X. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1388656 · Cited by 10
Wang, L., Lou, Y., Jiang, Q., Wang, H., Huang, S., Xie, Y., Wang, F., & Cao, S. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119958 · Cited by 12
Nomogram for predicting the 12-year risk of ADL disability among older adults
Qi, W., Yin, Z., Sun, Y., Wei, L. S., & Wu, Y. (2022) · Aging Clinical and Experimental Research · doi:10.1007/s40520-022-02105-z · Cited by 10
Prognostic Value of Glycated Hemoglobin in Frail Older Diabetic Patients With Hip Fracture
Simone, P., Okoye, C., Calabrese, A. M., Niccolai, F., Polini, A., Caraccio, N., Calsolaro, V., & Monzani, F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.770400 · Cited by 9
He, H., Li, F., Zhu, Z., Liao, Y., Li, H., Zou, Y., & Peng, Y. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.04.026 · Cited by 10
Vadini, F., Simeone, P., Desideri, G., Liani, R., Tripaldi, R., Ciotti, S., Tartaro, A., Guagnano, M. T., Castelnuovo, A. F. D., Cipollone, F., et al. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.05.027 · Cited by 9
Demand Coupling Drives Neurodegeneration: A Model of Age-Related Cognitive Decline and Dementia
Turknett, J., & Wood, T. R. (2022) · Cells · doi:10.3390/cells11182789 · Cited by 9
“This includes significantly increased risk of ARCD and ARD as well as worse cognitive function associated with sedentary behavior and reduced physical activity [37,41–43], chronic sleep deprivation or sleep disruption [37,44,45], insulin resistance and dysglycemia [46,47], poor-quality nutrition and associated changes…”
BackgroundCochar‐Soares, N., de Oliveira, D. C., Luiz, M. M., Aliberti, M. J. R., Suemoto, C. K., Steptoe, A., de Oliveira, C. M., & Alexandre, T. D. S. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae136 · Cited by 8
“Participants were classified as “with controlled glycemia” when reported having diabetes, took or did not take medication for diabetes and had HbA1c 7%, or if they did not report having diabetes, did not take medication for diabetes, but had HbA1c between 6.5% and 7%, or if they did not report having diabetes, but too…”
BackgroundMethodInfluentialReduced Lung Function and Cognitive Decline in Aging: A Longitudinal Cohort Study
Xie, W., Zheng, F., Cai, Y. S., Han, X. B., Ma, Y., Hua, R., & Xie, L. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202009-1152rl · Cited by 7
Self-citationStoroschuk, K. L., Gharios, R., Potter, G. D., Galpin, A. J., House, B. T., & Wood, T. R. (2023) · Lifestyle Medicine · doi:10.1002/lim2.90 · Cited by 9
Miki, A., Kinno, R., Ochiai, H., Kubota, S., Mori, Y., Futamura, A., Sugimoto, A., Kuroda, T., Kasai, H., Yano, S., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.667215 · Cited by 8
“Since these diseases have been reported to be associated with dementia (Turana et al., 2019; Benn et al., 2017; Koch and Jensen, 2016; Zheng et al., 2018; Fan et al., 2017), this could have affected our current study findings.”
ResultInteraction of High-Sugar Diet and History of Stroke with Risk of Cognitive Decline in Older Adults
Xu, Q., Zhang, S., Gu, Y., Wang, P., Zhang, Q., & Shan, C. (2022) · Medical Science Monitor · doi:10.12659/msm.937572 · Cited by 7
Han, F., Kong, X., Lv, W., Li, S., Sun, Y., & Wu, Y. (2022) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2022.104827 · Cited by 10
Cognitive Dysfunction in Diabetes Mellitus
Shaikh, F. A., Bhuvan, K. C., Htar, T. T., Gupta, M., & Kumari, Y. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.85940 · Cited by 13
Xiao, H., Ding, K., Li, X., Zhou, Z., Ma, Y., Dai, X., Liu, Y., & Chen, D. (2025) · Sleep Medicine · doi:10.1016/j.sleep.2025.01.034 · Cited by 7
Song, S., Sung, M.-H., Díaz, D., Lin, Z., Tate, A. D., Chen, Z., Rajbhandari‐Thapa, J., Adams, G. B., Khan, M. M., Shen, Y., et al. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100194 · Cited by 7
“…means and Standard Deviations (SDs) of the baseline (i.e., 2004) sample were used in the calculation of Z-scores in all subsequent year operationalization of cognitive function Z-scores to avoid the influence of dropout (e.g., mortality selection and loss to follow-up) over the 16 years [ 54 , 55 ].”
Wang, Y., Fu, J., Liang, F., Oniffrey, T. M., Ding, K., Zeng, J., Moore, J. B., Luo, X., & Li, R. (2023) · Brain Sciences · doi:10.3390/brainsci13040658 · Cited by 8
“In the models, the intercept and slope were set as random effects, allowing for individual variations in baseline and the rates of change in cognitive function over time [37].”
Yu, W., Luo, R., He, C., Li, Z., Yang, M., Zhou, J., He, J., Chen, Q., Song, Z., & Cheng, S. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1339178 · Cited by 9
Wang, T., Jiang, H., Zheng, R., Zhang, C., Xiu-mei, M., & Liu, Y. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70524 · Cited by 9
“HbA1c, a measure of long-term glycemic control, is linearly associated with cognitive decline, particularly in memory and executive function [51, 52].”
Childhood Hypertension and Effects on Cognitive Functions: Mechanisms and Future Perspectives
Tyner, E., Oropeza, M., Figueroa, J. D., & Peña, I. D. (2019) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527318666191017155442 · Cited by 8
Morris, J. K., John, C. S., Green, Z. D., Wilkins, H., Wang, X., Kamat, A., Swerdlow, R. H., Vidoni, E. D., Petersen, M. E., O’Bryant, S. E., et al. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.608862 · Cited by 6
“This finding also underscores the important relationship between glucose regulation and cognitive function previously demonstrated in larger epidemiological studies (Altschul et al., 2018; Zheng et al., 2018), an effect may occur independently of large changes in brain structure.”
ResultDyer, A. H., Briggs, R., Laird, E. J., Hoey, L., Hughes, C., McNulty, H., Ward, M., Strain, J., Molloy, A. M., Cunningham, C. J., et al. (2021) · Diabetic Medicine · doi:10.1111/dme.14668 · Cited by 12
Kong, X., Han, F., Li, J., Wang, W., Sun, Y., & Wu, Y. (2023) · Aging & Mental Health · doi:10.1080/13607863.2023.2219626 · Cited by 6
Santoso, C. M. A., Stückler, D., & Ihle, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-25143-z · Cited by 8
Investigation of the Effects of Biochemical Parameters on Alzheimer’s Disease
Gokce, M., Bektay, M. Y., Selvitop, R., Toprak, A., & Yıldız, G. B. (2019) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317519862108 · Cited by 8
Shirai, Y., Kuriki, K., Otsuka, R., Kato, Y., Nishita, Y., Tange, C., Tomida, M., Imai, T., Ando, F., & Shimokata, H. (2019) · PubMed Central · doi:10.18999/nagjms.81.4.655 · Cited by 7
Gao, Y., Zhang, P., Yang, H., Li, S., Su, H., & Zhang, Q. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-06465-9 · Cited by 7
Wu, H., Huang, L., Zhang, S., Zhang, Y., & Lan, Y. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1294948 · Cited by 7
Anindya, K., Zhao, Y. W., Hoang, T. H.-L., Lee, J. T., Juvekar, S. K., Krishnan, A., Mbuma, V., Sharma, T., & Ng, N. (2024) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2024.105386 · Cited by 9
Kowall, B., & Rathmann, W. (2022) · Gerontology · doi:10.1159/000524571 · Cited by 6
Associations of hemoglobin A1c with cognition reduced for long diabetes duration
Silverman, J. M., Schmeidler, J., Lee, P., Alexander, N. B., Beeri, M. S., Guerrero‐Berroa, E., West, R. K., Sano, M. C., Nabozny, M., & Álvarez, C. R. (2019) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.11.009 · Cited by 5
Onyenekwe, B. M., Young, E. E., Nwatu, C. B., Okafor, C. I., Ugwueze, C. V., & Onuekwusi, K. O. (2019) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20194320 · Cited by 6
Kim, J. S., Chun, B. C., & Lee, K. H. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1417236 · Cited by 5
Zheng, W., Qin-Jie, X. I. N., Xiao-Na, W. A. N. G., Li, S., Wang, X., & Nie, S. (2025) · 老年心脏病学杂志:英文版 · doi:10.26599/1671-5411.2025.03.010 · Cited by 4
Zhang, Y., Zhu, R., Ge, L., Zhang, X., Tian, D., Pan, F., Wang, M., & Cai, G. (2024) · Maturitas · doi:10.1016/j.maturitas.2024.108057 · Cited by 4
Liu, Y., Wang, X., Ren, X., Zhang, C., Zhou, S., Wang, Y., Xu, J., Liu, L., Wang, Y., & Yuan, L. (2024) · Journal of the American Nutrition Association · doi:10.1080/27697061.2024.2401592 · Cited by 5
Association of time in range with cognitive impairment in middle-aged type 2 diabetic patients
Liu, Y., Liu, Y., Qiu, H.-N., Haghbin, N., Li, J., Li, Y., Jiang, W., Xia, L., Wu, F., Lin, C.-Y., et al. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01772-5 · Cited by 4
“After followed up 8.1(2.8) years, there was an association between HbA1c levels and cognitive decline [16].”
BackgroundInfluentialSinclair, D. R., Maharani, A., Clegg, A. P., Hanratty, B., Tampubolon, G., Todd, C. J., Wittenberg, R., O’Neill, T. W., & Matthews, F. E. (2025) · The Journal of Frailty & Aging · doi:10.1016/j.tjfa.2025.100012 · Cited by 6
Editorial: Epidemiology and clinical researches in atherosclerosis and cardiovascular disease
Gao, D., Cai, Y. S., Pan, Y., Ma, Q., & Xie, W. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1212269 · Cited by 4
Self-citationIzzati, R. A., & Pakpahan, E. (2025) · American Journal of Epidemiology · doi:10.1093/aje/kwaf129 · Cited by 3
“For example,individuals with diabetes tend to have cognitive impairment 11 as well as physical ability.”
Risk factors for cognitive impairment in type 2 diabetes patients
Mansour, A., Akhgarjand, C., Abadi, A. D. N., Danaei, S., Abaszadeh, Y., Torabi, F., Ghalandari, M., Eslamian, R., Hekmat, H., Nasli‐Esfahani, E., et al. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01788-1 · Cited by 4
“Some research found no significant association between HbA1c levels and cognitive decline [30 ], while others reported modest associations [ 31] or indicated an increased risk of dementia and cognitive decline [32, 33].”
Hua, J., Lou, Y., Guo, Y., Zhong, R., (王芙蓉), F. W., Jiang, Q., & Cao, S. (2026) · Journal of Clinical Hypertension · doi:10.1111/jch.70226 · Cited by 4
“Further details on cognitive testing are provided in the supplemental methods, and all tests have been validated with good reliability and validity [ 23–26 ] ( eMethods ).”
Han, S., Zhou, Y., Sturkenboom, M., Biessels, G. J., & Ahmadizar, F. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113311 · Cited by 6
Azami, M., Afraie, M., Mohammadzadeh, P., Moradkhani, A., Shanazari, M., Soltanian, D., & Moradi, Y. (2025) · Cognitive Neuropsychiatry · doi:10.1080/13546805.2025.2503445 · Cited by 6
“As a result, there is a relationship between them through similar underlying mechanisms, including inflammation, ischemia, atherosclerosis, and IR (Alcorn et al., 2019; Nash & Fillit, 2006; Qiu & Fratiglioni, 2015; Zheng et al., 2018).”
Dongaonkar, B., Singh, A. D., Hurakadli, S. B., & Godbole, A. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.08.008 · Cited by 4
“Participants were included if they had at least 10 years of school education and had basic English proficiency (read and communicate).”
InfluentialCuevas, H. E., & Ward, C. (2018) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.13085 · Cited by 3
Effects of glycemic control on frailty: a multidimensional perspective
Abdelhafiz, A. H. (2023) · Hospital Practice · doi:10.1080/21548331.2023.2203622 · Cited by 3
“reported data from the English longitudinal study of aging that showed a longitudinal association between HbA1c levels and rate of decline in global cognition [69].”
BackgroundMultivariate single index modeling of longitudinal data with multiple responses
Tian, Z., & Qiu, P. (2023) · Statistics in Medicine · doi:10.1002/sim.9763 · Cited by 4
Teng, Z., Feng, J., Xie, X., Xu, J., Jiang, X. J., & Lv, P. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s451862 · Cited by 3
Differences in lipidome and metabolome organization of prefrontal cortex among human populations
Tkachev, A., Stepanova, V. V., Zhang, L., Khrameeva, E. E., Zubkov, D., Giavalisco, P., & Khaitovich, P. (2019) · Scientific Reports · doi:10.1038/s41598-019-53762-6 · Cited by 3
Sreedevi, K., Sukumari‐Ramesh, S., Geetha, M., & Appukuttan, P. S. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.11005 · Cited by 3
“Supporting this conclusion are previous reports that diabetes is the most common predisposing factor for Alzheimer's disease (AD) (38,39).”
ResultGlucose Trajectory: More than Changing Glucose Tolerance with Age?
Swislocki, A. (2022) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2021.0093 · Cited by 4
Shen, J., Li, K., Yu, H., Ding, B., Xiao, R., & Ma, W. (2021) · Research Square · doi:10.21203/rs.3.rs-577863/v1 · Cited by 2
Editorial: Epidemiology and clinical researches on neuropsychiatric disorders in aging
Xie, W., Zhong, B., Liang, L., & Cai, Y. S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1108474 · Cited by 3
Self-citationJanthakhin, Y., Juntapremjit, S., Hummel, K., Razzazi‐Fazeli, E., & Kingtong, S. (2024) · Bioinformatics and Biology Insights · doi:10.1177/11779322241306290 · Cited by 4
Li, X., Chen, B., Liu, X., & Ma, J. (2025) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.15061 · Cited by 3
Iktilat, K., Isaacson, M., Tzemah-Shahar, R., & Agmon, M. (2025) · PLoS ONE · doi:10.1371/journal.pone.0321450 · Cited by 2
Trajectories of Cognitive Decline Before and After New‐Onset Hypertension
Chen, Q., Dong, J., Chen, G., Li, H., Shen, Y., & Hua, J. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.039849 · Cited by 2
Yang, Q., Qiao, Y., Shi, P., & Huang, Z. (2025) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2025.100744 · Cited by 2
“Cognitive function was assessed following methods used in prior studies [36,37].”
Zhang, X., Zhao, J., Zhao, B., & LI, X. (2025) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003911 · Cited by 2
GLP-1 agonists in neurodegeneration: a multimodal biomarker-guided approach
Santiago, J. A., Gutierrez-Silva, J. C., Hsu, W.-C., Sanchez, K., Almanza, C., Ramos, W., Haq, I. U., & Rundek, T. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2025.12.001 · Cited by 4
Deng, M., Wang, G., Gao, X., Wang, Y., Ni, Y., Chen, Y., Xu, J., & Jiang, W. J. (2022) · Journal of Addictive Diseases · doi:10.1080/10550887.2022.2120791 · Cited by 3
“17 In addition, alcohol consumption is reportedly associated with reduced HbA1c levels in the general population.”
BackgroundXing, X., Wang, Y., Shen, Z., Pan, F., & Cai, G. (2023) · Diabetic Medicine · doi:10.1111/dme.15180 · Cited by 3
Mahmoudi, R., Kamari, F., Sadeh, R. N., Naseri, A., & Sadra, V. (2024) · European journal of medical research · doi:10.1186/s40001-024-01925-1 · Cited by 2
COVID-19 and Cognitive Decline in Older Adults with High-Cardiovascular Risk: A Post Hoc Analysis
Shyam, S., Martínez, C. G., Ni, J., Gaforio, J. J., Martínez‐González, M. Á., Corella, D., Martínez, J. A., Alonso‐Gómez, Á. M., Wärnberǵ, J., Vioqué, J., et al. (2024) · Aging and Disease · doi:10.14336/ad.2024.0380 · Cited by 6
Wood, D., Evangelopoulos, D., Kitwiroon, N., Stewart, G. B., Vu, T. V., Smith, J. D. B., Beevers, S. D., & Katsouyanni, K. (2025) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/s41370-025-00745-7 · Cited by 3
“Tests of word recall and the animal naming test have been shown to display good construct validity both in ELSA and other cohorts [29, 30].”
Sex-Specific Multimorbidity–Multibehaviour Patterns in Primary Care Populations
Spyropoulos, K., Ellis, N., & Gidlow, C. J. (2025) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph22040485 · Cited by 3
“Diabetes is associated with CHD, PVD, stroke [35], diverticular disease [36], cognitive decline [37], and dementia.”
Hua, J., Dong, J., Chen, Y., Li, H., & Chen, Q. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.040211 · Cited by 4
Is the lack of appropriate cognitive demand the primary driver of dementia risk?
Wood, T. R., & Turknett, J. (2022) · Lifestyle Medicine · doi:10.1002/lim2.70 · Cited by 2
Hemoglobin A1c and 10-year information processing speed in Japanese community dwellers
Otsuka, R., Nishita, Y., Tange, C., Tomida, M., Ando, F., & Shimokata, H. (2019) · Environmental Health and Preventive Medicine · doi:10.1186/s12199-019-0778-8 · Cited by 2
“However, the results of longitudinal studies are not consistent [2, 5, 7, 8].”
BackgroundNeurological Complications of Diabetes Mellitus
Starchina, Y. A., & Zakharov, V. V. (2019) · Effective Pharmacotherapy · doi:10.33978/2307-3586-2019-15-19-30-37 · Cited by 2
Wang, K., Gao, H., Sijbrands, E. J. G., Kavousi, M., & Ahmadizar, F. (2023) · Maturitas · doi:10.1016/j.maturitas.2023.03.009 · Cited by 2
Diabetes mellitus and neurodegenerative disorders
Amin, S. N., Albakri, K. A., Alabdallat, Y. J., & Elberry, D. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00009-9 · Cited by 1
Chatterjee, S., Bhattacharjee, R., Sinha, A., Maiti, A., Mukherjee, A., Ghosh, R., & Dubey, S. (2025) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1900_24 · Cited by 3
White Matter Hyperintensities Mediate the Negative Impact of HbA1c Levels on Cognitive Function
Johnstone, R., Rangus, I., Busby, N., Wilmskoetter, J., Riccardi, N., Newman-Norlund, S. E., Newman‐Norlund, R., Rorden, C., Fridriksson, J., & Bonilha, L. (2025) · Brain Sciences · doi:10.3390/brainsci15070692 · Cited by 2
“The relationship between elevated HbA1c, as seen in type 2 diabetes, and impaired cognitive function is well-established, though the underlying mechanisms remain under investigation [2,3].”
Yan, R., Hu, Y., Yang, J., Chang, J., Wang, H., Wang, Y., & Song, G. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120388 · Cited by 4
Yin, R., Tian, Y., Ma, M., Jing, G., & Zhang, M. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.10.254 · Cited by 1
Golchin, A., Johnson, K., Houston, D. K., Luchsinger, J. A., Beavers, K. M., Bertoni, A. G., Chen, H., Wagenknecht, L. E., & Espeland, M. A. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109227 · Cited by 3
“…on cognitive tests.26 More generally, elevated HbA1c levels have been shown to be related to increased risks for cognitive decline and impairment.27,28 However, we note that the large, well-powered Memory in Diabetes (ACCORD-MIND) clinical trial found intensive pharmacological lowering of HbA1c…”
Chen, S., Chen, B., Shao, J., Zou, M., Zhou, J., Teng, J., Cai, F., & Huang, P. (2026) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2026.105351 · Cited by 1
Gong, H., Zou, M., Xu, J., Tu, Y., Chen, H., Shao, T., Ji, F., Wang, H., & Huang, P. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121299 · Cited by 1
Saluja, K. V., Balachandran, P., Pillai, D., Meena, D., Saxena, S., Khokhar, H., Khandelwal, G., Manoj, S., Chittora, S., & Bhadra, P. (2026) · Scientific Reports · doi:10.1038/s41598-026-44608-z · Cited by 1
Smart Drug-Delivery Approaches for Enhanced Management of Comorbid Conditions in Alzheimer’s Disease
Stanciu, G. D., Costăchescu, I., Dascalu, C., & Tamba, B.-I. (2026) · Life · doi:10.3390/life16030510 · Cited by 2
Metadata
- Authors
- Zheng, F., Yan, L., Yang, Z., Zhong, B., & Xie, W.
- Affiliations
- Chinese Academy of Sciences (CN)
- Imperial College London (GB)
- Peking University (CN)
- Corresponding author
- Xie, Wuxiang
- Venue
- Diabetologia
- Published
- 2018-01-25
- Volume
- 61
- Issue
- 4
- Pages
- 839-848
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC6448974
- OpenAlex
- W2791177277
- Cited by
- 280
- References
- 32
- Citations by year
- 2026: 31 · 2025: 54 · 2024: 35 · 2023: 35 · 2022: 30 · 2021: 34 · 2020: 24 · 2019: 24 · 2018: 13
- FWCI
- 18.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- Locations
- Diabetologia (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Funders
- Academy of Medical Sciences (P56804)
- National Natural Science Foundation of China (81601176)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- HbA1c, diabetes mellitus, prediabetes, cognitive decline, memory, executive function, older adults, English Longitudinal Study of Ageing, glycemic control, dementia risk, HbA1c thresholds, cognitive function trajectories, HbA1c trajectories, diabetes subtypes
- MeSH terms
- Aged, Blood Glucose, Cognition, Cross-Sectional Studies, Diabetes Mellitus, England, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Longitudinal Studies, Male, Memory, Middle Aged, Reproducibility of Results, Treatment Outcome, Diabetes Complications, Executive Function, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.